about
Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomesSeizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome.Data collection and interpretation.Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage.Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study.Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome.Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study.Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome.Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage.Tonic-clonic activity at subarachnoid hemorrhage onset: impact on complications and outcomeCerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage.Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage.Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhageMultimodality monitoring: informatics, integration data display and analysis.Multimodality monitoring for cerebral perfusion pressure optimization in comatose patients with intracerebral hemorrhage.Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhagePearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation.Causal Structure of Brain Physiology after Brain Injury from Subarachnoid Hemorrhage.Subarachnoid hemorrhage: who dies, and why?Nutritional support and brain tissue glucose metabolism in poor-grade SAH: a retrospective observational study.Real time estimation of brain water content in comatose patients.Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhagePatient-Powered Reporting of Modified Rankin Scale Outcomes Via the Internet.Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcomeMultimodality monitoring in neurocritical care.Resuscitation and critical care of poor-grade subarachnoid hemorrhage.High-dose midazolam infusion for refractory status epilepticusEffect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke.Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage.Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhage.Ultra-early angiographic vasospasm associated with delayed cerebral ischemia and infarction following aneurysmal subarachnoid hemorrhage.Predictors of long-term shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Clinical article.Risk factors for catheter-associated urinary tract infections in critically ill patients with subarachnoid hemorrhage.Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury.Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol.Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction SyndromeAnemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage.Cerebral microbleeds in patients with acute subarachnoid hemorrhage.Intracortical electroencephalography in acute brain injury.Intracerebral monitoring of silent infarcts after subarachnoid hemorrhage.
P50
Q30544942-4031051F-74E5-4751-B7F8-FF85E1DDBE88Q30703796-DC822706-A2AF-4E67-A455-6F874268A49FQ30924720-F7BA70B9-7FAD-456C-B39C-68673383BFB0Q33697166-440C60A8-C0F3-4053-99B2-EE4A063D42DAQ33752318-67F71AB5-3DB4-445F-BEB1-E90AFB9BAEDFQ33856333-FCECF03C-0DFD-48BF-8A5B-E927FF339158Q33892365-DBC0BD6F-7378-4B4F-B3CF-EFC8E2E0C5D6Q34018874-88AAF545-AE7F-4EE3-850E-DC453EFF455FQ34344828-0497E287-07F3-4FB7-BE43-4DF5BE718E77Q34949499-973ABABB-486C-4332-9125-5396C63D8A60Q34951946-BB7BBA5F-A95F-4D91-83FB-7CA4833B092BQ35106607-159C6888-E43B-47D0-A264-B332D6421EF3Q35154916-4F5300D1-C413-4BAE-A8AB-88E4CF4D013AQ35246499-C4BC002B-82A8-424B-A0F1-ACD11EBD068FQ35449746-7D9DC8F7-126F-497C-8813-69E5DDDF9E4DQ35623045-A7E93D2A-8553-45D3-B707-22E8AB30225BQ35758678-C062D38B-131D-4805-A097-B9DA8186749DQ36001623-93715676-6DED-45B8-9AB4-9837C06D27EEQ36015756-52BE6C76-B3A2-49EF-9D19-14655D5D96D9Q36093519-E5E1C6D4-DD72-45EF-BA36-1FAAEFDD8F04Q36297701-10A455C9-AA3E-41EE-92E4-9ACD4D9BF2EDQ36304075-4C0295C0-5078-47A5-9C60-798EF75D5F3AQ36376183-A4831FE5-A6C7-475A-92BB-80B80EFBB7D7Q36637976-3A4D6D82-D658-4F09-9594-2D24E4F4B9D4Q36953769-75E2A5DF-C03C-4A0B-BCB8-E3FDCC5ACE5DQ37400544-9FBA2F43-64A0-4A0C-9243-1F66BF358C17Q37593258-81A7A1F2-3E60-41E1-BC58-C5B497300ECDQ37795389-15BE0CDC-BDDD-47BD-91A2-56F078201391Q37800041-6B6E4C47-E764-46D6-BE16-4B09C97FC9DFQ38051271-DEC22068-7998-48C9-85C0-1C0437FCDAAAQ39731872-997AFFA5-E94E-49AA-B145-ACA8AFA91F51Q39885928-CBD9232E-8BD9-460A-B016-939B65FD61CAQ40243528-371EB536-C2C9-49DA-AEA0-812CB7CB1993Q40329103-81204A2C-331A-4791-BE1D-6D63C9927BF2Q40338227-38D6524E-7E5E-4A8D-BD78-43A1F46FF42FQ40785141-5F1624AF-22BD-471D-A540-7548B6F8C918Q43103440-4D8B5D36-352C-4B31-8D27-92B8991A785BQ43487107-3DDF364D-03CE-47B4-B8DC-458050B616CCQ43520407-59201FAC-5701-4C49-8A1F-24854DEA96F6Q45363415-1DE7B9E4-0423-4B2B-9334-B9B56343375D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
J. Michael Schmidt
@ast
J. Michael Schmidt
@en
J. Michael Schmidt
@es
J. Michael Schmidt
@nl
J. Michael Schmidt
@sl
type
label
J. Michael Schmidt
@ast
J. Michael Schmidt
@en
J. Michael Schmidt
@es
J. Michael Schmidt
@nl
J. Michael Schmidt
@sl
prefLabel
J. Michael Schmidt
@ast
J. Michael Schmidt
@en
J. Michael Schmidt
@es
J. Michael Schmidt
@nl
J. Michael Schmidt
@sl
P106
P21
P31
P3835
michael-schmidt38
P496
0000-0001-8141-2944